BSXHealthcareLarge-Cap

BOSTON SCIENTIFIC CORP Insider Trading Activity

Every SEC Form 4 insider transaction reported for BOSTON SCIENTIFIC CORP (BSX), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are BSX insiders buying or selling?

BOSTON SCIENTIFIC CORP insiders reported 11 open-market buys ($11.1M) and 337 sells ($523.0M) across 348 Form 4 filings — a net selling position of $511.9M.

Source: SEC EDGAR Form 4

Key Statistics (as of Aug 26, 2026)

Total Form 4 filings
348
SEC EDGAR
Insider filers
32
Insider buys (11)
$11.1M
Insider sells (337)
$523.0M

Insider sentiment

Net selling

Net insider flow of $511.9M in net selling. 5 insider buys in the last 90 days.

Recent BSX insider transactions

DateInsiderRoleTypeSharesPriceValue
Aug 26, 2026Susan E MoranoDirectorPurchase2.0K$49.22$100.4K
Aug 7, 2026David C HabigerDirectorPurchase2.1K$47.59$99.9K
Aug 5, 2026David C HabigerDirectorPurchase1.2K$48.13$56.9K
Aug 5, 2026Michael F MahoneyChairman, President & CEOPurchase186.2K$48.33$9.0M
Aug 3, 2026Edward J LudwigDirectorPurchase5.0K$45.48$227.4K
May 21, 2026Cheryl PegusDirectorPurchase1.8K$56.49$100.0K
May 21, 2026Edward J LudwigDirectorPurchase3.6K$56.68$202.9K
May 21, 2026David C HabigerDirectorPurchase4.5K$56.43$251.1K
Feb 3, 2026Michael F MahoneyChairman, President & CEOSale160.9K$93.49$15.0M
Dec 2, 2025Arthur C ButcherEVP& Grp Pres, MedSurg & APACSale17.3K$101.55$1.8M
Nov 6, 2025Ellen M ZaneDirectorSale12.9K$98.28$1.3M
Nov 4, 2025Joseph Michael FitzgeraldEVP & Group Pres, CardiologySale50.0K$99.47$5.0M
Oct 28, 2025Ellen M ZaneDirectorSale12.9K$101.38$1.3M
Oct 1, 2025Joseph Michael FitzgeraldEVP & Group Pres, CardiologySale50.0K$98.47$4.9M
Sep 3, 2025Joseph Michael FitzgeraldEVP & Group Pres, CardiologySale50.0K$105.43$5.3M
Aug 4, 2025Joseph Michael FitzgeraldEVP & Group Pres, CardiologySale50.0K$104.63$5.2M
Aug 4, 2025Arthur C ButcherEVP& Grp Pres, MedSurg & APACSale17.3K$104.63$1.8M
Jul 30, 2025Yoshiaki FujimoriDirectorSale2.9K$106.99$310.4K
Jul 28, 2025Edward J LudwigDirectorSale4.0K$106.03$424.1K
Jul 2, 2025Joseph Michael FitzgeraldEVP & Group Pres, CardiologySale50.0K$106.97$5.3M
Jun 4, 2025Joseph Michael FitzgeraldEVP & Group Pres, CardiologySale56.4K$102.88$5.8M
Jun 3, 2025Michael F MahoneyChairman, President & CEOSale164.4K$103.69$17.1M
May 30, 2025Edward J LudwigDirectorSale4.0K$104.59$418.4K
May 22, 2025Vance R BrownSVP, GC and Corp. SecretarySale4.8K$106.42$513.6K
May 6, 2025John Bradley SorensonEVP, Global OperationsSale4.6K$104.54$478.0K

Showing the 25 most recent of 348 Form 4 filings for BOSTON SCIENTIFIC CORP.

Most active BSX insiders

  • David A Pierce62 filings
  • Wendy Carruthers41 filings
  • Jeffrey B. Mirviss32 filings
  • Michael F Mahoney24 filings
  • Arthur C Butcher22 filings

Ask anything about BSX insider activity

Use Trabud's AI agent to query BOSTON SCIENTIFIC CORP's Form 4 history in plain English — "Show me BSX CEO purchases this year" or compare it against any other ticker.

Open the AI agent

BSX insider trading FAQ

Are BOSTON SCIENTIFIC CORP insiders buying or selling?

Across 348 SEC Form 4 filings, BOSTON SCIENTIFIC CORP (BSX) insiders reported 11 open-market purchases totaling $11.1M and 337 sales totaling $523.0M. That is a net selling position of $511.9M.

How many insiders trade BSX stock?

32 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for BOSTON SCIENTIFIC CORP. The most recent filing was accepted on Aug 26, 2026.

Where does Trabud get BSX insider trading data?

All BSX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content